Kumar Neil, CEO of BridgeBio Pharma ($BBIO), sold shares on the open market 93 times over the past year, totaling $54.3 million. His most recent sale occurred on February 19, 2026. These sales rank 294th among nearly 12,000 insiders in our database, surpassing the average of $8.6 million per seller and 6.4 transactions. Neil made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 27, 2026 | Maze Therapeutics, Inc. | $MAZE | Kumar Neil | Not found | A | Stock Option (Right to Buy) | 33417 | $0.00 | 33,417.0000 | 48,119,444 | 9999.99% | 0.07% |
| March 17, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | A | Stock Option (Right to Buy) | 40570 | $0.00 | 40,570.0000 | 192,708,813 | 9999.99% | 0.02% |
| March 17, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | A | Restricted Stock Units | 104313 | $0.00 | 104,313.0000 | 192,708,813 | 9999.99% | 0.05% |
| March 12, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 300 | $70.15 | 5,328,584.0000 | 192,708,813 | 0.01% | 0.00% |
| March 12, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 14337 | $68.48 | 5,334,247.0000 | 192,708,813 | 0.27% | 0.01% |
| March 12, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 13885 | $68.47 | 5,334,699.0000 | 192,708,813 | 0.26% | 0.01% |
| March 12, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 5363 | $69.32 | 5,328,884.0000 | 192,708,813 | 0.10% | 0.00% |
| March 12, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 300 | $70.15 | 5,328,584.0000 | 192,708,813 | 0.01% | 0.00% |
| March 13, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 9690 | $68.36 | 5,318,894.0000 | 192,708,813 | 0.18% | 0.01% |
| March 13, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 10310 | $69.20 | 5,308,584.0000 | 192,708,813 | 0.19% | 0.01% |
| March 13, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 10241 | $68.39 | 5,318,343.0000 | 192,708,813 | 0.19% | 0.01% |
| March 13, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 9759 | $69.23 | 5,308,584.0000 | 192,708,813 | 0.18% | 0.01% |
| March 12, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 5815 | $69.29 | 5,328,884.0000 | 192,708,813 | 0.11% | 0.00% |
| Feb. 19, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 602 | $72.80 | 5,388,584.0000 | 192,708,813 | 0.01% | 0.00% |
| Feb. 19, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 18923 | $71.03 | 5,397,714.0000 | 192,708,813 | 0.35% | 0.01% |
| Feb. 19, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 8528 | $72.08 | 5,389,186.0000 | 192,708,813 | 0.16% | 0.00% |
| Feb. 16, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 33544 | $0.00 | 134,176.0000 | 192,708,813 | 20.00% | 0.02% |
| Feb. 16, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Common Stock | 33544 | $0.00 | 5,416,453.0000 | 192,708,813 | 0.62% | 0.02% |
| Feb. 16, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Common Stock | 19600 | $0.00 | 5,436,053.0000 | 192,708,813 | 0.36% | 0.01% |
| Feb. 16, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Common Stock | 11554 | $0.00 | 5,447,607.0000 | 192,708,813 | 0.21% | 0.01% |
| Feb. 16, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | F | Common Stock | 30970 | $75.25 | 5,416,637.0000 | 192,708,813 | 0.57% | 0.02% |
| Feb. 16, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 11554 | $0.00 | 138,645.0000 | 192,708,813 | 7.69% | 0.01% |
| Feb. 16, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 19600 | $0.00 | 156,794.0000 | 192,708,813 | 11.11% | 0.01% |
| Feb. 11, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 3775 | $71.46 | 5,391,274.0000 | 192,708,813 | 0.07% | 0.00% |
| Feb. 11, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 7860 | $70.70 | 5,395,049.0000 | 192,708,813 | 0.15% | 0.00% |
| Feb. 11, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 3994 | $73.25 | 5,382,909.0000 | 192,708,813 | 0.07% | 0.00% |
| Feb. 11, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 4484 | $72.64 | 5,386,903.0000 | 192,708,813 | 0.08% | 0.00% |
| Feb. 11, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 3716 | $71.44 | 5,391,387.0000 | 192,708,813 | 0.07% | 0.00% |
| Feb. 11, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 7806 | $70.69 | 5,395,103.0000 | 192,708,813 | 0.14% | 0.00% |
| Feb. 11, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 4404 | $72.65 | 5,386,870.0000 | 192,708,813 | 0.08% | 0.00% |
| Feb. 11, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 3961 | $73.25 | 5,382,909.0000 | 192,708,813 | 0.07% | 0.00% |
| Feb. 10, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 5960 | $72.27 | 5,402,909.0000 | 192,708,813 | 0.11% | 0.00% |
| Feb. 10, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 14040 | $71.80 | 5,408,869.0000 | 192,708,813 | 0.26% | 0.01% |
| Feb. 10, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 5799 | $72.28 | 5,402,909.0000 | 192,708,813 | 0.11% | 0.00% |
| Feb. 10, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 14201 | $71.80 | 5,408,708.0000 | 192,708,813 | 0.26% | 0.01% |
| Jan. 9, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 6955 | $76.72 | 5,473,803.0000 | 192,708,813 | 0.13% | 0.00% |
| Jan. 9, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 1855 | $78.10 | 5,462,909.0000 | 192,708,813 | 0.03% | 0.00% |
| Jan. 9, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 10677 | $77.46 | 5,464,764.0000 | 192,708,813 | 0.19% | 0.01% |
| Jan. 9, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 6067 | $76.53 | 5,475,441.0000 | 192,708,813 | 0.11% | 0.00% |
| Jan. 9, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 1401 | $75.61 | 5,481,508.0000 | 192,708,813 | 0.03% | 0.00% |
| Jan. 9, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 375 | $78.19 | 5,462,909.0000 | 192,708,813 | 0.01% | 0.00% |
| Jan. 9, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 10519 | $77.61 | 5,463,284.0000 | 192,708,813 | 0.19% | 0.01% |
| Jan. 9, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 2151 | $75.75 | 5,480,758.0000 | 192,708,813 | 0.04% | 0.00% |
| Jan. 8, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 300 | $75.20 | 5,482,909.0000 | 192,708,813 | 0.01% | 0.00% |
| Jan. 8, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 8135 | $74.38 | 5,483,209.0000 | 192,708,813 | 0.15% | 0.00% |
| Jan. 8, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 11565 | $73.65 | 5,491,344.0000 | 192,708,813 | 0.21% | 0.01% |
| Jan. 8, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 400 | $75.16 | 5,482,909.0000 | 192,708,813 | 0.01% | 0.00% |
| Jan. 8, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 8085 | $74.38 | 5,483,309.0000 | 192,708,813 | 0.15% | 0.00% |
| Jan. 8, 2026 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 11515 | $73.64 | 5,491,394.0000 | 192,708,813 | 0.21% | 0.01% |
| Dec. 12, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | F | Common Stock | 30964 | $75.15 | 5,572,920.0000 | 192,708,813 | 0.55% | 0.02% |
| Dec. 15, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 28311 | $74.60 | 5,544,609.0000 | 192,708,813 | 0.51% | 0.01% |
| Dec. 15, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 1700 | $75.24 | 5,542,909.0000 | 192,708,813 | 0.03% | 0.00% |
| Dec. 12, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 60975 | $0.00 | 60,976.0000 | 192,708,813 | 50.00% | 0.03% |
| Dec. 12, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Common Stock | 60975 | $0.00 | 5,603,884.0000 | 192,708,813 | 1.10% | 0.03% |
| Dec. 5, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 12517 | $73.05 | 5,550,392.0000 | 192,708,813 | 0.23% | 0.01% |
| Dec. 4, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 5708 | $74.80 | 5,562,909.0000 | 192,708,813 | 0.10% | 0.00% |
| Dec. 4, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 12192 | $74.42 | 5,568,617.0000 | 192,708,813 | 0.22% | 0.01% |
| Dec. 4, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 2100 | $73.16 | 5,580,809.0000 | 192,708,813 | 0.04% | 0.00% |
| Dec. 5, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 7712 | $73.75 | 5,542,909.0000 | 192,708,813 | 0.14% | 0.00% |
| Dec. 4, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 5700 | $74.80 | 5,562,909.0000 | 192,708,813 | 0.10% | 0.00% |
| Dec. 4, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 12200 | $74.42 | 5,568,609.0000 | 192,708,813 | 0.22% | 0.01% |
| Dec. 4, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 2100 | $73.16 | 5,580,809.0000 | 192,708,813 | 0.04% | 0.00% |
| Dec. 5, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 7483 | $73.76 | 5,542,909.0000 | 192,708,813 | 0.13% | 0.00% |
| Dec. 5, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 12288 | $73.04 | 5,550,621.0000 | 192,708,813 | 0.22% | 0.01% |
| Nov. 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 6401 | $64.97 | 5,642,664.0000 | 192,708,813 | 0.11% | 0.00% |
| Nov. 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 5456 | $66.71 | 5,622,909.0000 | 192,708,813 | 0.10% | 0.00% |
| Nov. 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 14299 | $65.90 | 5,628,365.0000 | 192,708,813 | 0.25% | 0.01% |
| Nov. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Common Stock | 19599 | $0.00 | 5,670,366.0000 | 192,708,813 | 0.35% | 0.01% |
| Nov. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Common Stock | 11554 | $0.00 | 5,681,920.0000 | 192,708,813 | 0.20% | 0.01% |
| Nov. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | F | Common Stock | 32855 | $66.39 | 5,649,065.0000 | 192,708,813 | 0.58% | 0.02% |
| Nov. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 33544 | $0.00 | 167,720.0000 | 192,708,813 | 16.67% | 0.02% |
| Nov. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 19599 | $0.00 | 176,394.0000 | 192,708,813 | 10.00% | 0.01% |
| Nov. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 11554 | $0.00 | 150,199.0000 | 192,708,813 | 7.14% | 0.01% |
| Nov. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Common Stock | 33544 | $0.00 | 5,650,767.0000 | 192,708,813 | 0.60% | 0.02% |
| Nov. 7, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 200 | $62.81 | 5,617,223.0000 | 192,708,813 | 0.00% | 0.00% |
| Nov. 7, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 7308 | $61.87 | 5,617,423.0000 | 192,708,813 | 0.13% | 0.00% |
| Nov. 7, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 12492 | $61.14 | 5,624,731.0000 | 192,708,813 | 0.22% | 0.01% |
| Nov. 6, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 12576 | $62.91 | 5,644,647.0000 | 192,708,813 | 0.22% | 0.01% |
| Nov. 7, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 220 | $62.79 | 5,617,223.0000 | 192,708,813 | 0.00% | 0.00% |
| Nov. 7, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 7546 | $61.87 | 5,617,443.0000 | 192,708,813 | 0.13% | 0.00% |
| Nov. 7, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 12234 | $61.13 | 5,624,989.0000 | 192,708,813 | 0.22% | 0.01% |
| Nov. 6, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 100 | $64.39 | 5,637,223.0000 | 192,708,813 | 0.00% | 0.00% |
| Nov. 6, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 7371 | $63.56 | 5,637,323.0000 | 192,708,813 | 0.13% | 0.00% |
| Nov. 6, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 12529 | $62.91 | 5,644,694.0000 | 192,708,813 | 0.22% | 0.01% |
| Nov. 6, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 100 | $64.39 | 5,637,223.0000 | 192,708,813 | 0.00% | 0.00% |
| Nov. 6, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 7324 | $63.55 | 5,637,323.0000 | 192,708,813 | 0.13% | 0.00% |
| Oct. 9, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 20000 | $54.80 | 5,697,223.0000 | 190,188,626 | 0.35% | 0.01% |
| Oct. 8, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 11295 | $55.09 | 5,717,223.0000 | 190,188,626 | 0.20% | 0.01% |
| Oct. 8, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 8706 | $54.39 | 5,728,517.0000 | 190,188,626 | 0.15% | 0.00% |
| Oct. 8, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 11294 | $55.09 | 5,717,223.0000 | 190,188,626 | 0.20% | 0.01% |
| Oct. 9, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 20000 | $54.80 | 5,697,223.0000 | 190,188,626 | 0.35% | 0.01% |
| Oct. 8, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 8705 | $54.39 | 5,728,518.0000 | 190,188,626 | 0.15% | 0.00% |
| Sept. 5, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 800 | $53.80 | 5,777,223.0000 | 190,188,626 | 0.01% | 0.00% |
| Sept. 4, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 14525 | $51.15 | 5,802,698.0000 | 190,188,626 | 0.25% | 0.01% |
| Sept. 4, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 5475 | $51.85 | 5,797,223.0000 | 190,188,626 | 0.09% | 0.00% |
| Sept. 5, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 2300 | $51.95 | 5,794,923.0000 | 190,188,626 | 0.04% | 0.00% |
| Sept. 5, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 16800 | $53.16 | 5,778,123.0000 | 190,188,626 | 0.29% | 0.01% |
| Sept. 5, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 900 | $53.80 | 5,777,223.0000 | 190,188,626 | 0.02% | 0.00% |
| Sept. 4, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 14558 | $51.16 | 5,802,665.0000 | 190,188,626 | 0.25% | 0.01% |
| Sept. 4, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 5442 | $51.85 | 5,797,223.0000 | 190,188,626 | 0.09% | 0.00% |
| Sept. 5, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 2300 | $51.96 | 5,794,923.0000 | 190,188,626 | 0.04% | 0.00% |
| Sept. 5, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 16900 | $53.16 | 5,778,023.0000 | 190,188,626 | 0.29% | 0.01% |
| Aug. 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 25728 | $48.81 | 5,857,651.0000 | 190,188,626 | 0.44% | 0.01% |
| Aug. 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 428 | $49.25 | 5,857,223.0000 | 190,188,626 | 0.01% | 0.00% |
| Aug. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | F | Common Stock | 32855 | $51.32 | 5,883,379.0000 | 190,188,626 | 0.56% | 0.02% |
| Aug. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 33544 | $0.00 | 201,264.0000 | 190,188,626 | 14.29% | 0.02% |
| Aug. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 19599 | $0.00 | 195,993.0000 | 190,188,626 | 9.09% | 0.01% |
| Aug. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 11554 | $0.00 | 161,753.0000 | 190,188,626 | 6.67% | 0.01% |
| Aug. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Common Stock | 64697 | $0.00 | 5,916,234.0000 | 190,188,626 | 1.11% | 0.03% |
| Aug. 8, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 11795 | $45.88 | 5,859,742.0000 | 190,188,626 | 0.20% | 0.01% |
| Aug. 7, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 6784 | $45.09 | 5,884,753.0000 | 190,188,626 | 0.12% | 0.00% |
| Aug. 7, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 13216 | $45.64 | 5,871,537.0000 | 190,188,626 | 0.22% | 0.01% |
| Aug. 8, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 11795 | $45.88 | 5,859,742.0000 | 190,188,626 | 0.20% | 0.01% |
| Aug. 8, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 8205 | $46.71 | 5,851,537.0000 | 190,188,626 | 0.14% | 0.00% |
| Aug. 7, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 6784 | $45.09 | 5,884,753.0000 | 190,188,626 | 0.12% | 0.00% |
| Aug. 7, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 13216 | $45.64 | 5,871,537.0000 | 190,188,626 | 0.22% | 0.01% |
| Aug. 8, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 8205 | $46.71 | 5,851,537.0000 | 190,188,626 | 0.14% | 0.00% |
| July 1, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 18400 | $42.51 | 5,953,137.0000 | 190,188,626 | 0.31% | 0.01% |
| July 1, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 18300 | $42.50 | 5,953,237.0000 | 190,188,626 | 0.31% | 0.01% |
| July 1, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 1700 | $42.88 | 5,951,537.0000 | 190,188,626 | 0.03% | 0.00% |
| July 2, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 20000 | $42.73 | 5,931,537.0000 | 190,188,626 | 0.34% | 0.01% |
| July 1, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 1600 | $42.89 | 5,951,537.0000 | 190,188,626 | 0.03% | 0.00% |
| July 2, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 20000 | $42.73 | 5,931,537.0000 | 190,188,626 | 0.34% | 0.01% |
| May 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 11553 | $0.00 | 173,307.0000 | 190,188,626 | 6.25% | 0.01% |
| May 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Common Stock | 64696 | $0.00 | 6,070,547.0000 | 190,188,626 | 1.08% | 0.03% |
| May 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | F | Common Stock | 32854 | $33.84 | 6,037,693.0000 | 190,188,626 | 0.54% | 0.02% |
| May 19, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 25756 | $33.32 | 6,011,937.0000 | 190,188,626 | 0.43% | 0.01% |
| May 19, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 400 | $33.75 | 6,011,537.0000 | 190,188,626 | 0.01% | 0.00% |
| May 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 75000 | $33.40 | 6,011,537.0000 | 190,188,626 | 1.23% | 0.04% |
| May 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 33544 | $0.00 | 234,808.0000 | 190,188,626 | 12.50% | 0.02% |
| May 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 19599 | $0.00 | 215,592.0000 | 190,188,626 | 8.33% | 0.01% |
| April 22, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 75000 | $34.11 | 6,080,851.0000 | 190,188,626 | 1.22% | 0.04% |
| March 25, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 75000 | $36.87 | 6,155,851.0000 | 190,188,626 | 1.20% | 0.04% |
| March 19, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | A | Stock Option (Right to Buy) | 71208 | $0.00 | 71,208.0000 | 190,188,626 | 9999.99% | 0.04% |
| March 19, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | A | Restricted Stock Units | 184860 | $0.00 | 184,860.0000 | 190,188,626 | 9999.99% | 0.10% |
| Feb. 25, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 37899 | $33.36 | 6,267,952.0000 | 190,188,626 | 0.60% | 0.02% |
| Feb. 25, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 37101 | $33.79 | 6,230,851.0000 | 190,188,626 | 0.59% | 0.02% |
| Feb. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Common Stock | 55539 | $0.00 | 6,361,390.0000 | 190,188,626 | 0.88% | 0.03% |
| Feb. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | F | Common Stock | 23996 | $34.90 | 6,337,394.0000 | 190,188,626 | 0.38% | 0.01% |
| Feb. 19, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 31467 | $36.14 | 6,305,927.0000 | 190,188,626 | 0.50% | 0.02% |
| Feb. 19, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 76 | $36.56 | 6,305,851.0000 | 190,188,626 | 0.00% | 0.00% |
| Feb. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 2395 | $0.00 | 0.0000 | 190,188,626 | 100.00% | 0.00% |
| Feb. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 33544 | $0.00 | 268,352.0000 | 190,188,626 | 11.11% | 0.02% |
| Feb. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 19600 | $0.00 | 235,191.0000 | 190,188,626 | 7.69% | 0.01% |
| Jan. 28, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 326932 | $36.29 | 6,578,919.0000 | 0 | 4.73% | 0.00% |
| Jan. 29, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 269068 | $36.34 | 6,309,851.0000 | 0 | 4.09% | 0.00% |
| Jan. 29, 2025 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 4000 | $36.82 | 6,305,851.0000 | 0 | 0.06% | 0.00% |
| Dec. 24, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | G | Common Stock | 4685725 | $0.00 | 6,905,851.0000 | 0 | 40.42% | 0.00% |
| Dec. 24, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | G | Common Stock | 4685725 | $0.00 | 6,905,851.0000 | 0 | 211.06% | 0.00% |
| Dec. 10, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | A | Restricted Stock Units | 121951 | $0.00 | 121,951.0000 | 0 | 9999.99% | 0.00% |
| Nov. 19, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 25514 | $22.39 | 6,907,726.0000 | 0 | 0.37% | 0.00% |
| Nov. 19, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 1875 | $22.76 | 6,905,851.0000 | 0 | 0.03% | 0.00% |
| Nov. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 33544 | $0.00 | 301,896.0000 | 0 | 10.00% | 0.00% |
| Nov. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Common Stock | 55537 | $0.00 | 6,961,388.0000 | 0 | 0.80% | 0.00% |
| Nov. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | F | Common Stock | 28148 | $23.72 | 6,933,240.0000 | 0 | 0.40% | 0.00% |
| Nov. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 2394 | $0.00 | 2,395.0000 | 0 | 49.99% | 0.00% |
| Nov. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 19599 | $0.00 | 254,791.0000 | 0 | 7.14% | 0.00% |
| Aug. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 2394 | $0.00 | 4,789.0000 | 0 | 33.33% | 0.00% |
| Aug. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 19599 | $0.00 | 274,390.0000 | 0 | 6.67% | 0.00% |
| Aug. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Common Stock | 55537 | $0.00 | 6,961,388.0000 | 0 | 0.80% | 0.00% |
| Aug. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | F | Common Stock | 28148 | $24.40 | 6,933,240.0000 | 0 | 0.40% | 0.00% |
| Aug. 19, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 16192 | $24.39 | 6,905,851.0000 | 0 | 0.23% | 0.00% |
| Aug. 19, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | S | Common Stock | 11197 | $25.13 | 6,905,851.0000 | 0 | 0.16% | 0.00% |
| Aug. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | Chief Executive Officer | M | Restricted Stock Units | 33544 | $0.00 | 335,440.0000 | 0 | 9.09% | 0.00% |
| May 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 2394 | $0.00 | 7,183.0000 | 0 | 25.00% | 0.00% |
| May 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 19599 | $0.00 | 293,989.0000 | 0 | 6.25% | 0.00% |
| May 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 33544 | $0.00 | 368,984.0000 | 0 | 8.33% | 0.00% |
| May 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 5130 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | F | Common Stock | 30748 | $31.04 | 6,905,851.0000 | 0 | 0.44% | 0.00% |
| May 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Common Stock | 60667 | $0.00 | 6,936,599.0000 | 0 | 0.88% | 0.00% |
| March 12, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | A | Restricted Stock Units | 313588 | $0.00 | 313,588.0000 | 0 | 9999.99% | 0.00% |
| March 12, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | A | Stock Option (right to buy) | 45140 | $0.00 | 45,140.0000 | 0 | 9999.99% | 0.00% |
| Feb. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Common Stock | 102249 | $0.00 | 6,923,854.0000 | 0 | 1.50% | 0.00% |
| Feb. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | F | Common Stock | 47922 | $37.21 | 6,875,932.0000 | 0 | 0.69% | 0.00% |
| Feb. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 5129 | $0.00 | 5,130.0000 | 0 | 50.00% | 0.00% |
| Feb. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 2394 | $0.00 | 9,577.0000 | 0 | 20.00% | 0.00% |
| Feb. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 33544 | $0.00 | 402,528.0000 | 0 | 7.69% | 0.00% |
| Feb. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 61182 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Common Stock | 102249 | $0.00 | 6,923,854.0000 | 0 | 1.50% | 0.00% |
| Nov. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 33544 | $0.00 | 436,072.0000 | 0 | 7.14% | 0.00% |
| Nov. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 61182 | $0.00 | 61,182.0000 | 0 | 50.00% | 0.00% |
| Nov. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 2394 | $0.00 | 11,971.0000 | 0 | 16.67% | 0.00% |
| Nov. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 5129 | $0.00 | 10,259.0000 | 0 | 33.33% | 0.00% |
| Nov. 17, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | S | Common Stock | 200 | $29.55 | 6,821,605.0000 | 0 | 0.00% | 0.00% |
| Nov. 17, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | S | Common Stock | 51352 | $29.10 | 6,821,805.0000 | 0 | 0.75% | 0.00% |
| Nov. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | F | Common Stock | 50697 | $28.86 | 6,873,157.0000 | 0 | 0.73% | 0.00% |
| Aug. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Common Stock | 102250 | $0.00 | 6,923,855.0000 | 0 | 1.50% | 0.00% |
| Aug. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 33544 | $0.00 | 469,616.0000 | 0 | 6.67% | 0.00% |
| Aug. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 61182 | $0.00 | 122,364.0000 | 0 | 33.33% | 0.00% |
| Aug. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 2394 | $0.00 | 14,365.0000 | 0 | 14.28% | 0.00% |
| Aug. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 5130 | $0.00 | 15,388.0000 | 0 | 25.00% | 0.00% |
| Aug. 17, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | S | Common Stock | 51552 | $28.59 | 6,821,605.0000 | 0 | 0.75% | 0.00% |
| Aug. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | F | Common Stock | 50698 | $29.80 | 6,873,157.0000 | 0 | 0.73% | 0.00% |
| May 17, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | S | Common Stock | 51552 | $14.01 | 6,821,605.0000 | 0 | 0.75% | 0.00% |
| May 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | F | Common Stock | 50697 | $14.09 | 6,873,157.0000 | 0 | 0.73% | 0.00% |
| May 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Common Stock | 102249 | $0.00 | 6,923,854.0000 | 0 | 1.50% | 0.00% |
| May 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 2394 | $0.00 | 16,759.0000 | 0 | 12.50% | 0.00% |
| May 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 5129 | $0.00 | 20,518.0000 | 0 | 20.00% | 0.00% |
| May 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 33544 | $0.00 | 503,160.0000 | 0 | 6.25% | 0.00% |
| May 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 61182 | $0.00 | 183,546.0000 | 0 | 25.00% | 0.00% |
| May 3, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | S | Common Stock | 120000 | $14.18 | 6,821,605.0000 | 0 | 1.73% | 0.00% |
| April 5, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | S | Common Stock | 120000 | $15.46 | 6,941,605.0000 | 0 | 1.70% | 0.00% |
| March 3, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | S | Common Stock | 120000 | $10.96 | 7,061,605.0000 | 0 | 1.67% | 0.00% |
| Feb. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Common Stock | 68706 | $0.00 | 7,250,311.0000 | 0 | 0.96% | 0.00% |
| Feb. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 2395 | $0.00 | 19,153.0000 | 0 | 11.11% | 0.00% |
| Feb. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 5129 | $0.00 | 25,647.0000 | 0 | 16.67% | 0.00% |
| Feb. 17, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | S | Common Stock | 44798 | $12.70 | 7,181,605.0000 | 0 | 0.62% | 0.00% |
| Feb. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | F | Common Stock | 23908 | $12.64 | 7,226,403.0000 | 0 | 0.33% | 0.00% |
| Feb. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | M | Restricted Stock Units | 61182 | $0.00 | 244,728.0000 | 0 | 20.00% | 0.00% |
| Feb. 10, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | A | Restricted Stock Units | 536704 | $0.00 | 536,704.0000 | 0 | 9999.99% | 0.00% |
| Feb. 10, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | A | Stock Option (Right to Buy) | 624652 | $0.00 | 624,652.0000 | 0 | 9999.99% | 0.00% |
| Feb. 3, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | S | Common Stock | 120000 | $11.01 | 7,181,605.0000 | 0 | 1.64% | 0.00% |
| Jan. 5, 2023 | BridgeBio Pharma, Inc. | $BBIO | Kumar Neil | CEO and President | S | Common Stock | 120000 | $7.67 | 7,301,605.0000 | 0 | 1.62% | 0.00% |